Cargando…

Optimizing E. coli as a formatotrophic platform for bioproduction via the reductive glycine pathway

Microbial C1 fixation has a vast potential to support a sustainable circular economy. Hence, several biotechnologically important microorganisms have been recently engineered for fixing C1 substrates. However, reports about C1-based bioproduction with these organisms are scarce. Here, we describe th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seohyoung, Giraldo, Néstor, Rainaldi, Vittorio, Machens, Fabian, Collas, Florent, Kubis, Armin, Kensy, Frank, Bar-Even, Arren, Lindner, Steffen N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885119/
https://www.ncbi.nlm.nih.gov/pubmed/36726742
http://dx.doi.org/10.3389/fbioe.2023.1091899
_version_ 1784879862473818112
author Kim, Seohyoung
Giraldo, Néstor
Rainaldi, Vittorio
Machens, Fabian
Collas, Florent
Kubis, Armin
Kensy, Frank
Bar-Even, Arren
Lindner, Steffen N.
author_facet Kim, Seohyoung
Giraldo, Néstor
Rainaldi, Vittorio
Machens, Fabian
Collas, Florent
Kubis, Armin
Kensy, Frank
Bar-Even, Arren
Lindner, Steffen N.
author_sort Kim, Seohyoung
collection PubMed
description Microbial C1 fixation has a vast potential to support a sustainable circular economy. Hence, several biotechnologically important microorganisms have been recently engineered for fixing C1 substrates. However, reports about C1-based bioproduction with these organisms are scarce. Here, we describe the optimization of a previously engineered formatotrophic Escherichia coli strain. Short-term adaptive laboratory evolution enhanced biomass yield and accelerated growth of formatotrophic E. coli to 3.3 g-CDW/mol-formate and 6 h doubling time, respectively. Genome sequence analysis revealed that manipulation of acetate metabolism is the reason for better growth performance, verified by subsequent reverse engineering of the parental E. coli strain. Moreover, the improved strain is capable of growing to an OD(600) of 22 in bioreactor fed-batch experiments, highlighting its potential use for industrial bioprocesses. Finally, demonstrating the strain’s potential to support a sustainable, formate-based bioeconomy, lactate production from formate was engineered. The optimized strain generated 1.2 mM lactate —10% of the theoretical maximum— providing the first proof-of-concept application of the reductive glycine pathway for bioproduction.
format Online
Article
Text
id pubmed-9885119
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98851192023-01-31 Optimizing E. coli as a formatotrophic platform for bioproduction via the reductive glycine pathway Kim, Seohyoung Giraldo, Néstor Rainaldi, Vittorio Machens, Fabian Collas, Florent Kubis, Armin Kensy, Frank Bar-Even, Arren Lindner, Steffen N. Front Bioeng Biotechnol Bioengineering and Biotechnology Microbial C1 fixation has a vast potential to support a sustainable circular economy. Hence, several biotechnologically important microorganisms have been recently engineered for fixing C1 substrates. However, reports about C1-based bioproduction with these organisms are scarce. Here, we describe the optimization of a previously engineered formatotrophic Escherichia coli strain. Short-term adaptive laboratory evolution enhanced biomass yield and accelerated growth of formatotrophic E. coli to 3.3 g-CDW/mol-formate and 6 h doubling time, respectively. Genome sequence analysis revealed that manipulation of acetate metabolism is the reason for better growth performance, verified by subsequent reverse engineering of the parental E. coli strain. Moreover, the improved strain is capable of growing to an OD(600) of 22 in bioreactor fed-batch experiments, highlighting its potential use for industrial bioprocesses. Finally, demonstrating the strain’s potential to support a sustainable, formate-based bioeconomy, lactate production from formate was engineered. The optimized strain generated 1.2 mM lactate —10% of the theoretical maximum— providing the first proof-of-concept application of the reductive glycine pathway for bioproduction. Frontiers Media S.A. 2023-01-16 /pmc/articles/PMC9885119/ /pubmed/36726742 http://dx.doi.org/10.3389/fbioe.2023.1091899 Text en Copyright © 2023 Kim, Giraldo, Rainaldi, Machens, Collas, Kubis, Kensy, Bar-Even and Lindner. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Kim, Seohyoung
Giraldo, Néstor
Rainaldi, Vittorio
Machens, Fabian
Collas, Florent
Kubis, Armin
Kensy, Frank
Bar-Even, Arren
Lindner, Steffen N.
Optimizing E. coli as a formatotrophic platform for bioproduction via the reductive glycine pathway
title Optimizing E. coli as a formatotrophic platform for bioproduction via the reductive glycine pathway
title_full Optimizing E. coli as a formatotrophic platform for bioproduction via the reductive glycine pathway
title_fullStr Optimizing E. coli as a formatotrophic platform for bioproduction via the reductive glycine pathway
title_full_unstemmed Optimizing E. coli as a formatotrophic platform for bioproduction via the reductive glycine pathway
title_short Optimizing E. coli as a formatotrophic platform for bioproduction via the reductive glycine pathway
title_sort optimizing e. coli as a formatotrophic platform for bioproduction via the reductive glycine pathway
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885119/
https://www.ncbi.nlm.nih.gov/pubmed/36726742
http://dx.doi.org/10.3389/fbioe.2023.1091899
work_keys_str_mv AT kimseohyoung optimizingecoliasaformatotrophicplatformforbioproductionviathereductiveglycinepathway
AT giraldonestor optimizingecoliasaformatotrophicplatformforbioproductionviathereductiveglycinepathway
AT rainaldivittorio optimizingecoliasaformatotrophicplatformforbioproductionviathereductiveglycinepathway
AT machensfabian optimizingecoliasaformatotrophicplatformforbioproductionviathereductiveglycinepathway
AT collasflorent optimizingecoliasaformatotrophicplatformforbioproductionviathereductiveglycinepathway
AT kubisarmin optimizingecoliasaformatotrophicplatformforbioproductionviathereductiveglycinepathway
AT kensyfrank optimizingecoliasaformatotrophicplatformforbioproductionviathereductiveglycinepathway
AT barevenarren optimizingecoliasaformatotrophicplatformforbioproductionviathereductiveglycinepathway
AT lindnersteffenn optimizingecoliasaformatotrophicplatformforbioproductionviathereductiveglycinepathway